🇺🇸 FDA
Patent

US 6685967

Methods and compositions for pulmonary delivery of insulin

expired A61KA61K38/28A61K47/12

Quick answer

US patent 6685967 (Methods and compositions for pulmonary delivery of insulin) held by Nektar Therapeutics expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/28, A61K47/12, A61K47/183, A61K47/26